Literature DB >> 3107691

Malignant hypertension in women of childbearing age and its relation to the contraceptive pill.

K G Lim, C G Isles, G P Hodsman, A F Lever, J W Robertson.   

Abstract

Eleven of 34 women aged 15-44 with malignant phase hypertension were taking oral contraceptives at presentation. All had had normal blood pressure before starting to take the pill. In four the interval between the start of oral contraception and the diagnosis of malignant hypertension was less than four months, and in eight no other cause for the hypertension was found. Underlying renal disease and renal failure were less common among pill users than among non-users with malignant hypertension who were of similar age. No pill user became normotensive after withdrawal of the pill, but blood pressure was well controlled (diastolic less than 90 mm Hg) in three patients taking only one drug. By contrast, all 23 non-users needed two or more antihypertensive drugs to control blood pressure. Ten year survival was 90% among pill users and 50% among non-users. These results suggest that oral contraceptives may be a common cause of malignant hypertension in women of child-bearing age. If the pill is stopped and underlying renal disease excluded the long term prognosis for such patients is excellent.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3107691      PMCID: PMC1246219          DOI: 10.1136/bmj.294.6579.1057

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  16 in total

1.  Abnormalities of coagulation and the development of malignant phase hypertension.

Authors:  H Gavras; N Oliver; J Aitchison; C Begg; J D Briggs; J J Brown; P W Horton; F Lee; A F Lever; C Prentice; J I Robertson
Journal:  Kidney Int Suppl       Date:  1975-09       Impact factor: 10.545

2.  Malignant hypertension associated with use of oral contraceptives.

Authors:  F G Dunn; J V Jones; R Fife
Journal:  Br Heart J       Date:  1975-03

3.  [Malignant arterial hypertension and oral contraceptives. Apropos of 4 cases].

Authors:  Y Saint-Hillier; N Baumont; H Colomb; G Pageaut; C Perol
Journal:  J Urol Nephrol (Paris)       Date:  1977-09

4.  Irreversible renal failure secondary to hypertension induced by oral contraceptives.

Authors:  B J Zacherle; J A Richardson
Journal:  Ann Intern Med       Date:  1972-07       Impact factor: 25.391

5.  Malignant hypertension associated with oral contraceptives.

Authors:  P W Harris
Journal:  Lancet       Date:  1969-08-30       Impact factor: 79.321

6.  Blood pressure in women taking oral contraceptives.

Authors:  R J Weir; E Briggs; A Mack; L Naismith; L Taylor; E Wilson
Journal:  Br Med J       Date:  1974-03-23

7.  Oral contraceptives and severe hypertension.

Authors:  M R Wallace
Journal:  Aust N Z J Med       Date:  1971-02

8.  Investigation of relation between use of oral contraceptives and thromboembolic disease.

Authors:  M P Vessey; R Doll
Journal:  Br Med J       Date:  1968-04-27

9.  Intrarenal vascular changes in patients receiving oestrogen-containing compounds--a clinical, histological and angiographic study.

Authors:  W N Boyd; R P Burden; G M Aber
Journal:  Q J Med       Date:  1975-07

10.  Myocardial infarction and other vascular diseases in young women. Role of estrogens and other factors.

Authors:  H Jick; B Dinan; R Herman; K J Rothman
Journal:  JAMA       Date:  1978-12-01       Impact factor: 56.272

View more
  5 in total

1.  Chronic estradiol-17β exposure increases superoxide production in the rostral ventrolateral medulla and causes hypertension: reversal by resveratrol.

Authors:  Madhan Subramanian; Priya Balasubramanian; Hannah Garver; Carrie Northcott; Huawei Zhao; Joseph R Haywood; Gregory D Fink; Sheba M J MohanKumar; P S MohanKumar
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-03-16       Impact factor: 3.619

2.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

3.  Young-adult hypertension as a presentation of familial renal disease.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-04       Impact factor: 3.738

4.  Hypertension in women of reproductive age in the United States: NHANES 1999-2008.

Authors:  Brian T Bateman; Kate M Shaw; Elena V Kuklina; William M Callaghan; Ellen W Seely; Sonia Hernández-Díaz
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

5.  Malignant Hypertension in Association with Low Estrogen Dose Oral Contraceptives: Case Report and Review of Literature.

Authors:  Danial Mir; Arash Ardabilygazir; Sonia Afshariyamchlou; Issac Sachmechi
Journal:  Cureus       Date:  2018-07-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.